CD8A and urinary bladder cancer: However, the CD4+:CD8+ TIL ratio was significantly lower in the group with the recurrence, or more specifically, this group had a greater number of CD8+ TILs, thus indicating that CD8+ TILs could be associated with bladder cancer recurrence.